Bendamustin in der Rezidivtherapie des Multiplen Myeloms
| LEADER | cam a22 4 4500 | ||
|---|---|---|---|
| 001 | 172313260 | ||
| 003 | CHVBK | ||
| 005 | 20200624112626.0 | ||
| 008 | 101207s2010 gw m 00 ger | ||
| 035 | |a (OCoLC)731510133 | ||
| 035 | |a (NEBIS)006241365 | ||
| 040 | |a SzZuIDS NEBIS ZBZ | ||
| 082 | 0 | |a 610 | |
| 100 | 1 | |a Michael |D Mark | |
| 245 | 1 | 0 | |a Bendamustin in der Rezidivtherapie des Multiplen Myeloms |c vorgelegt von Mark Michael |
| 260 | |a Düsseldorf |c 2010 | ||
| 300 | |a 49 Bl. |b Ill. | ||
| 502 | |a Diss. Univ. Düsseldorf, 2010 | ||
| 655 | 7 | |a Hochschulschrift |2 gnd-content | |
| 898 | |a BK020300 |b XK020000 |c XK020000 | ||
| 908 | |D 1 |a Hochschulschrift = Thèse/Mémoire | ||
| 909 | 7 | |a zbzdis201012e |c meip |d zbzswk201012d |2 idszbz Z2 | |
| 912 | 7 | |a ZB6169 |2 Z01 | |
| 949 | |B NEBIS |F Z01 |b Z0SBI |c ZBIND |j UnD 2010: 10250 | ||
| 950 | |B NEBIS |P 100 |E 1- |a Michael |D Mark | ||
| 956 | 4 | |B NEBIS |C ZAD50 |D EBI01 |a Z01 |u https://opac.nebis.ch/objects/pdf/z01_006241365_01.pdf |y Titelblatt und Inhaltsverzeichnis |x VIEW |q pdf | |